Company CVAbout Themis Medicare Ltd 
Themis Medicare Ltd
Small Cap
Pharmaceuticals & Drugs
Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
Company Coordinates
Company Details
Plot No 69 A GIDC Indl Estate, Vapi Valsad Gujarat : 396195
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 9.20 Cr
Number of Shares
9.2 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
19-Feb-2024
9.2
9.20
12420
1
Issued under ESOP Scheme
10-Oct-2023
9.2
9.20
82824930
1
Stock Split
27-Jan-2023
92.03
9.20
2500
10
Issued under ESOP Scheme
28-Feb-2022
92
9.20
730
10
Issued under ESOP Scheme
13-Aug-2021
92
9.20
5578
10
Issued under ESOP Scheme
27-May-2021
91.94
9.19
5508
10
Issued under ESOP Scheme
14-Aug-2020
91.88
9.19
462
10
Issued under ESOP Scheme
07-Feb-2020
91.88
9.19
7050
10
Issued under ESOP Scheme
27-Mar-2018
93.06
9.31
8249
10
ESOP
30-Jan-2018
92.98
9.30
125000
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
2.427
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 15 FIIs (0.1%)
Promoter with highest holding
Vividhmargi Investments Pvt (15.78%)
Highest Public shareholder
Anuj Anantrai Sheth (4.67%)
Individual Investors Holdings
24.24%
Board of Directors
Management
Designation
Remuneration
Rajneesh Anand
Non-Exec & Non-Independent Dir
4.1 lacs
VIJAY GOPI KISHAN AGARWAL
Independent Non Exe. Director
5.7 lacs
Hari Subramaniam
Independent Non Exe. Director
3.6 lacs
Reena S Patel
Non Executive Director
0
Sachin D Patel
ED / MD / CEO / Promoter
2.12 cr
Dinesh S Patel
Chairman & Independent Directo
2.15 cr
Manjul Sandhu
Independent Non Exe. Director
2.6 lacs
Bhaskar Vemban Iyer
Independent Non Exe. Director
5.2 lacs
Shishir Dalal
Additional Director
0
Reena S Patel
Alternate Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drug
182.93
99.36%
Other Operating Revenues
1.18
0.64%
Bulk Drug
Bulk Drug
Other Operating Revenues
Other Operating Revenues
Stock DNARevenue and Profits:
Net Sales:
94 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
Pharmaceuticals & Drugs
INR 1,145 Cr (Small Cap)
23.00
33
0.43%
0.16
12.86%
2.59
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
